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Abstract
Background: Expression quantitative trait loci (eQTL) databases represent a valuable resource to link disease-
associated SNPs to specific candidate genes whose gene expression is significantly modulated by the SNP under
investigation. We previously identified signal inhibitory receptor on leukocytes-1 (SIRL-1) as a powerful regulator of
human innate immune cell function. While it is constitutively high expressed on neutrophils, on monocytes the
SIRL-1 surface expression varies strongly between individuals. The underlying mechanism of regulation, its genetic
control as well as potential clinical implications had not been explored yet.
Methods: Whole blood eQTL data of a Chinese cohort was used to identify SNPs regulating the expression of
VSTM1, the gene encoding SIRL-1. The genotype effect was validated by flow cytometry (cell surface expression),
correlated with electrophoretic mobility shift assay (EMSA), chromatin immunoprecipitation (ChIP) and bisulfite
sequencing (C-methylation) and its functional impact studied the inhibition of reactive oxygen species (ROS).
Results: We found a significant association of a single CpG-SNP, rs612529T/C, located in the promoter of VSTM1.
Through flow cytometry analysis we confirmed that primarily in the monocytes the protein level of SIRL-1 is
strongly associated with genotype of this SNP. In monocytes, the T allele of this SNP facilitates binding of the
transcription factors YY1 and PU.1, of which the latter has been recently shown to act as docking site for modifiers
of DNA methylation. In line with this notion rs612529T associates with a complete demethylation of the VSTM1
promoter correlating with the allele-specific upregulation of SIRL-1 expression. In monocytes, this upregulation
strongly impacts the IgA-induced production of ROS by these cells. Through targeted association analysis we found
a significant Meta P value of 1.14 × 10–6 for rs612529 for association to atopic dermatitis (AD).
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Conclusion: Low expression of SIRL-1 on monocytes is associated with an increased risk for the manifestation of an
inflammatory skin disease. It thus underlines the role of both the cell subset and this inhibitory immune receptor in
maintaining immune homeostasis in the skin. Notably, the genetic regulation is achieved by a single CpG-SNP,
which controls the overall methylation state of the promoter gene segment.
Keywords: VSTM1, Signal inhibitory receptor on leukocytes-1 (SIRL-1), Expression quantitative trait loci (eQTL),
Atopic dermatitis, Monocytes, Reactive oxygen species (ROS), Neutrophils
Background
Genome-wide association studies (GWAS) in the recent
past have identified thousands of disease-related genetic
variants and trait-associated polymorphisms [1–3]. The
National Genome Research Institute (NHGRI) GWAS
catalog alone comprises data of more than 2000 different
studies organized with association P values from hun-
dreds of disease phenotypes and complex traits [4].
However, translating these associated variants to causal-
ity and potential mechanisms of disease have been diffi-
cult. Recent advances in high throughput genotyping
and gene expression analysis have allowed for an exten-
sive mapping of expressed quantitative trait loci (eQTL)
[5, 6]. Although many of these eQTL are cell-type–
specific and also vary between the ethnic groups, they
represent a valuable resource for candidate proteins,
whose messenger RNA (mRNA) expression is, at least
in part, genetically controlled [5–7]. These eQTL datasets
provide an excellent opportunity to address and under-
stand the mechanisms underlying GWAS hits. Zhu et al.
have recently demonstrated this at a whole genome level
by providing a list of priority candidate genes for further
functional evaluation of the five complex human traits
[8]. However, once the priority candidate genes have been
identified, it needs to be validated using well designed in
vitro, in vivo, or ex vivo models using techniques, which
go beyond assaying the genome and transcriptome
[9, 10]. Additionally, this also requires knowledge on
the protein molecule under investigation or pathways identi-
fied, cell/tissue specificity, and functional consequence
on the immune system. Hence, there is a need for tar-
geted but yet comprehensive candidate gene-based studies
looking at various aspects of the potential disease gene
from DNA to protein, also in pure populations of immune
cells and/or tissues with appropriate stimuli and func-
tional readouts. In this study, we present an in-depth,
well-characterized study of the SIRL-1 (signal inhibitory
receptor on leukocytes-1) gene using various complemen-
tary techniques.
The “immune inhibitory receptors” represent a hetero-
geneous family of transmembrane receptors that func-
tion as negative regulators of immune cells [11, 12].
Upon ligation, the inhibitory signal is transduced
through immunoreceptor tyrosine-based inhibitory
motifs (ITIMs) located in the cytoplasmic tail of the re-
ceptor [13]. One member of this family is SIRL-1. While
the natural ligand is not known yet, cross-linking of the
receptor with agonistic antibodies results in the tyrosine
phosphorylation of the ITIMs by the Src family kinases
(SFK). The phosphorylated ITIMs act as a docking site
for the recruitment of the Src homology 2 (SH2)
domain-containing tyrosine phosphatases SHP-1 and/or
SHP-2[14]. These phosphatases antagonize the effects of
activating SFK and Syk family kinases, triggered for in-
stance by the engagement of IgE-specific Fc-epsilon re-
ceptors [15]. Therefore, these immune inhibitory
receptors have been implicated to play a role in regulat-
ing antibody-mediated immune responses. SIRL-1 is
known to primarily express on human myeloid cells,
where it inhibits crucial pro-inflammatory functions,
such as Fc receptor (FcR) mediated respiratory burst and
neutrophil extracellular trap (NET) formation [12, 14,
16, 17]. In a prior study, we made an observation report-
ing striking differences in the expression level of SIRL-1
on various immune subsets. Granulocyte subsets neutro-
phils and eosinophils constitutively expressed high levels
SIRL-1 on most individuals, while the expression level of
the receptor on monocytes varied strongly between indi-
viduals [16]. The cause of these variations as well as the
potential clinical implications was not known.
In this study, we used mRNA and genotype data from two
independent cohorts (Chinese, Caucasian) to link population
variations of the molecule on monocytes to a single single
nucleotide polymorphism (SNP), rs612529T/C, a CpG-SNP
located in the promoter region of the SIRL-1 encoding gene
VSTM1. By employing flow cytometry (FACS), functional
assays, electrophoretic mobility shift assay (EMSA), bisulfite
DNA sequencing, and chromatin immune precipitation
(ChIP) analysis, we could further show that SIRL-1 upregu-
lation correlates with the allele dependent binding of PU.1
and YY1 to the CpG-SNP, which in turn is associated with a
demethylation of the entire promoter region. Importantly,
genetic association analysis suggested that the cell-type–spe-
cific fluctuations of SIRL-1 indeed might have pathologic
consequences. We observed that in three independent co-
horts, the C allele (indicative of low expression) is consist-
ently associated with an increased risk for atopic dermatitis
(AD), an inflammatory skin condition.
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Methods
Human blood samples and cohorts
The cohorts used in this study were outlined in
Additional file 1. eQTL analysis was carried out with
ethnic Chinese cohorts collected in Singapore (“blood
eQTL cohort” and “monocyte & B cell eQTL cohort”) of
202 (unpublished) and 15 individuals [18], respectively.
In addition, data were used from a “Monocyte & B cell
cohort” of 279 individuals of Caucasian ethnicity that
had been reported before by Fairfax et al. [19] With the
exception of the “functional cohort” (see below), details
on all cohorts had been published previously. Data of
three additional cohorts (Singapore Chinese population
[20], Chinese Han Population [21] and Caucasian popu-
lation [22]) that had been published previously were
used for the genetic association of the VSTM1-SNP
rs612529 with AD.
Functional cohort
Another genotyped Singaporean cohort consisting of
ethnic Chinese individuals was used for the functional
characterization of VSTM1 by FACS (n = 44), reactive
oxygen species (ROS) assay (n = 30), DNA-methylation
(n = 8), and ChIP assay (n = 9) (“functional cohort”). For
all individuals of the “functional cohort,” the rs612529T/
C genotype was determined by using high resolution
melting (HRM) analysis. The functional cohort was used
for the rs612529 genotype/phenotype association, meas-
urement of NADPH oxidase mediated ROS production
assay, ChIP assay and bisulfite treatment, and methyla-
tion analysis as described below.
Genotyping
DNA was isolated from whole blood or peripheral blood
mononuclear cells (PBMCs) using DNeasy Blood &
Tissue Kits (Qiagen) according to the manufacturer’s in-
structions. For targeted genotyping, the HRM analysis
was performed by real-time polymerase chain reaction
(PCR) using a CFX96 Real-Time Detection System (Bio-
Rad). The primers used for rs612529 genotyping were
5′-TCTTGGCAGAACTTCAGATAAGGT-3′ (forward)
and 5′-ACAAGAAGCCGTCGATGATAACT-3′ (reverse).
Amplification was carried out using the following protocol:
3 min at 95 °C, 40 cycles of 5 s at 95 °C, 5 s at 50 °C, and
final extension for 10 s at 95 °C. A melting curve was gen-
erated in the range of 65–95 °C (in 0.2 °C increments) with
10 s/step. Heterozygosity and homozygosity of the allelic
state were deduced using Precision Melting Analysis soft-
ware (Bio-Rad).
RNA extraction and global gene expression for whole
blood samples
Total RNA was extracted from human whole blood col-
lected in Tempus Blood RNA tubes (ThermoFisher)
using the MagMAX™ for Stabilized Blood Tubes RNA
Isolation Kit (ThermoFisher). Total RNA was sub-
jected to globin mRNA depletion using the Ambion
GLOBINclear kit (ThermoFisher). Agilent Bioanalyzer
was used to evaluate total RNA integrity and the RNA
Integrity Number (RIN) was calculated. All samples had
RIN in the range of 4.7–8.8; however, the median value
was 7. For genome-wide gene expression profiling,
fluorescent-labeled PCR products were prepared accord-
ing to Illumina Human Whole-Genome Gene Expression
DASL Assay Guide. The labeled products were hybridized
onto the Illumina HumanHT-12-v4 Expression Bead ChIP
for 16 h at 58 °C. These arrays were washed, coated based
on the Assay Guide, and scanned using Bead Array
Scanner 500GX at BSF Microarray Facility.
eQTL analysis
The whole blood cohort used for eQTL analysis has not
been published yet. The median age is 21 years and 55%
male. Whole blood gene expression data were processed
using the Bioconductor lumi package in R 3.1.2. The
gene expression data were quantile normalized and log2
transformed prior to further analysis. Whole blood gene
expression data for genes located 200kbp upstream and
downstream of the SNP rs612529 were extracted and
combined with the SNPs located within this same re-
gion. One-way ANOVAs were then done to determine if
any of the SNP genotypes associated with the gene ex-
pression levels. The one-way ANOVA was conducted in
R 3.1.2 and all resulting P values were corrected for mul-
tiple testing using the method of Benjamini and
Hochberg. The eQTL data for the B cells and monocytes
for the 15 samples for the Chinese samples from
Singapore were previously described in Melchiotti et al.
[18]. Data for the B cells and monocytes for the Caucasian
cohort were extracted from Fairfax et al. [19].
Association analysis for rs612529
The association analysis for the SNP rs612529 was per-
formed using statistics from the various cohorts using
Stouffer z-trend method using the Meta P program
(http://igm.cumc.columbia.edu/MetaP/metap.php). The
Stouffer’s z trend method considers P values, sample
sizes, and effect directions. For more information on the
program, refer to Whitlock et al. [23].
Flow cytometry analysis
Blood samples were collected in either BD K2EDTA or
citrate vacutainer tubes. FACS staining was performed
on either using whole blood sample or isolated PBMCs.
Erythrocytes were removed from whole blood by incuba-
tion in a 14-mL erythrocyte lysis buffer (155 mM
NH4Cl, 10 mM KHCO3, 0.1 mM EDTA) for 10 min at
room temperature. After erythrocytes lysis, the cells
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were centrifuged at 860 × g for 3 min. The cell pellets
were re-suspended in phosphate-buffered saline (PBS)
and washed once with PBS by centrifugation at 860 ×
g for 3 min at room temperature. For PBMC isola-
tion, whole blood was layered on Ficoll-Paque (GE
Healthcare) and centrifuged for 500 × g for 30 min with-
out a break. PBMCs were harvested at the interface be-
tween Ficoll and plasma layers. To discriminate the cells
live from the dead cells, lyzed whole blood samples or
PBMC cell pellets were incubated with 100 μL of LIVE/
DEAD Fixable Aqua Dead kit (Life Technologies) in PBS
for 10 min at room temperature. The cells were washed
once with 100 μL MACS buffer (0.5% BSA, 2 mM EDTA
in PBS) and transferred into 96 V-bottom plates for cen-
trifugation at 1000 × g for 3 min. For the SIRL-1 pheno-
typing, the cell pellets were incubated with for 15 min at
4 °C anti-SIRL-1 FITC (1A5; as previously described
[14]), anti-FcεRI PE (AER37; eBioscience), anti-CD123
PerCP Cy5.5 (6H6; eBioscience), anti-CD1c BV421
(L161; Biolegend), anti-CD14 PE-CF594 (MΦP9; BD
Biosciences), anti-CCR3 Alexa Fluor647 (5E8; Biolegend)
and anti-HLA-DR APC-H7 (L243; BD Biosciences). For
the correlation of SIRL-1 with Fc receptor expression, the
staining was carried out with anti-FcεR1 (AER37), anti-
CD16 (3G8; Biolegend), and anti-CD89 (A59; BD
Bioscience) monoclonal antibodies. After incubation, the
cell pellets were washed once with MACS buffer, re-
suspended in the 250 μL of the same buffer, and SIRL-1 ex-
pression level on different cell types was determined using
a LSRII or a Fortessa flow cytometer (BD Biosciences).
Cell isolation
Monocytes used for nuclear protein extraction were iso-
lated from apheresis blood and for ChIP and bisulfite se-
quencing monocytes were isolated from PBMCs derived
from functional cohort by positive selection using
MACS Human CD14 Microbeads (Miltenyi Biotec) ac-
cording to the instructions recommended by manufac-
turer. Neutrophils used for the bisulfite sequencing were
isolated by Ficoll-Paque density gradient centrifugation.
The neutrophils were isolated from the layer immedi-
ately above erythrocyte layer and lyzing the erythrocyte
with erythrocyte lysis buffer (155 mM NH4Cl, 10 mM
KHCO3, 0.1 mM EDTA) for 10 min at room
temperature on a roller mixer. The neutrophils were
washed once with cold RMPI1640 supplemented with
10% fetal bovine serum.
Measurement of NADPH oxidase mediated ROS
production
ROS production was measured in primary monocytes
isolated from frozen PBMC samples of genotyped do-
nors of the functional cohort. All experiments were per-
formed using technical duplicates. NADPH oxidase
activity was, unless otherwise indicated, assessed as H2O2
formation and determined by Amplex Red (Molecular
Probes), which reacts with H2O2 to produce fluorescent
resorufin in the presence of HRP (Sigma-Aldrich). The
assay was performed in microfluor white plates (Thermo
Scientific). Isolated monocytes were re-suspended in
HEPES buffer (20 mM HEPES, 132 mM NaCl, 6 mM KCl,
1 mM MgSO4, 1.2 mM KH2PO4, pH 7.4 supplemented
with 0.5% human serum albumin (Sigma), 1 mM Ca2+,
and 5 mM D-glucose) containing 50 μM Amplex Red and
1 U/mL HRP and stimulated (1 × 106 cells/mL) with
10 μg/mL plate-bound human IgA (ChromPure Human
IgA, Jackson ImmunoResearch Laboratories) together
with 10 μg/mL plate-bound anti-SIRL-1 (1A5) or an
isotype-matched control mAb (functional grade mouse
IgG clone:P3, eBioscience). Formation of H2O2 was mea-
sured directly from the start of stimulation, when cells
were added to coated wells, and continued for 1 h. Fluor-
escence was measured at 1-min intervals (λEx/λEm = 545/
590 nm) using a Tecan Infinite M200 PRO fluores-
cence reader (Tecan). Measurements were corrected
for spontaneous H2O2 production, as determined by
incubation of cells in non-coated wells. The percent-
age of SIRL-1-mediated inhibition of ROS production
was calculated by sub-traction of background H2O2
production and subsequent calculation of the area
under the curve of all samples. The AUC of IgA co-
coated with an isotype-matched control mAb was set
at 100% and compared with the AUC of IgA co-
coated with anti-SIRL-1 mAb.
Nuclear protein isolation
Freshly isolated monocytes from leukapheresis blood
were washed with ice cold PBS, then buffer A (20 mM
HEPES, pH 7.9, 20% Glycerol, 10 mM NaCl, 0.2 mM
EDTA (pH 8), 1 mM DTT, 0.1% Triton X-100) supple-
mented with Pierce Proteases and Phosphatase Inhibitor
Mini Tablets. The tablet contained aprotinin, bestatin, E-
64, EDTA, leupeptin, sodium fluoride, sodium orthova-
nadate, sodium pyrophosphate, beta-glycerophosphate,
and metalloproteinase inhibitor. After 15 min incubation
on ice, homogenates were centrifuged at 2000 rpm at 4 °C
for 15 min, and the resultant “nuclear pellets” were re-
suspended in buffer A containing 500 mM NaCl. The
nuclear proteins were incubated for 1 h on ice with inter-
mittent tapping followed by centrifugation at 13,000 rpm
(4 °C) for 15 min. The supernatants were then aliquoted
and snap-frozen at –80 °C until used. Quantitation of nu-
clear proteins was performed using Bio-Rad protein quan-
titation kit (Bio-Rad).
Electrophoretic mobility shift assay
The double-strand oligonucleotides had a length of
25 bp (the sequences are listed in Additional file 2).
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Allele-specific oligonucleotides corresponding to VSTM-
1 promoter region –34 to –58 were designed with the
C/T polymorphism of rs612529 in the center (termed as
“C probe” and “T probe”). C and T probes, as well as
MZF-1 consensus/mutant oligonucleotides, were synthe-
sized by 1st BASE, Singapore; all remaining oligonucleo-
tides were purchased from Santa Cruz Biotechnology.
32P labeling was introduced using T4 Polynucleotide
Kinase. For EMSA reactions, 5 μg of the monocyte nu-
clear protein extract was incubated with 40,000 cpm of
the 32P-labeled oligonucleotide probe in a total volume
of 20 μL 5 mM HEPES (pH 7.9), 5% glycerol, 0.5 mM
EDTA, 1 μg dIdC, 1 mM DTT, and 80 mM NaCl at 4 °C
for 45 min. For “cold” competition experiments, 12.5–
50 ng of the unlabeled oligonucleotide competitor
15 min were added before adding the respective radiola-
beled probe, representing a 12.5–50-fold excess of the
unlabeled competitor. For supershift assays, 2 uL of ei-
ther rabbit polyclonal anti-PU.1 IgG (H-135 X, Santa
Cruz Biotechnology) or rabbit polyclonal anti-YY1 IgG
(C-20, Santa Cruz Biotechnology) or rabbit IgG (Abcam)
were added 15 min before adding the respective radiola-
beled probe. After incubation, the DNA–protein com-
plexes were separated for 90 min with a 5% non-
denaturing polyacrylamide gel at 240 V on a protein II
gel-apparatus (Bio-Rad) using 0.5X Tris/Borate/EDTA
(TBE). After electrophoresis, the gel was transferred to a
Whatman paper and dried on a vacuum gel dryer (Gel
Dryer 583, Bio-Rad) for 2 h at 80 °C. The dried gel was
then exposed on an imaging plate and scanned using a
FLA-5000 phospho-image scanner (Fujifilm Life Science).
ChIP assay
ChIP assays were performed on monocytes isolated from
four CC-donors and five TT-donors (rs612529) of the
functional cohort. ChIP was carried out essentially as
previously described [24]. Briefly, DNA/protein cross-
linking was achieved by incubating the cells for 8 min at
37 °C in 1% formaldehyde. Ultrasound sonication of the
chromatin was performed in lysis buffer (50 mM Tris-Cl
pH 8.0, 10 mM EDTA, 1% SDS) with 3-min cycles (30 s
“ON”, 30 s “OFF”) for a total of ten cycles using a Bior-
uptor UCD-300 sonicator (Diagenode). After sonication,
samples were diluted in fivefold dilution buffer (0.01%
SDS,1.1% Triton X-100, 1.1 mM EDTA, 20 mM Tris-Cl
pH 8.0) followed by overnight incubation at 4 °C with
10 μg of either rabbit polyclonal anti-PU.1 antibody IgG
(H-135 X, Santa Cruz Biotechnology), or rabbit poly-
clonal IgG (Abcam). Real-time PCRs of genomic regions
containing the putative PU.1-binding site were per-
formed in triplicate by using iTaq SYBR green supermix
(Bio-Rad) with SIRL-1 specific primers (forward primer:
5′-TCTTGGCAGAACTTCAGATAAGGT-3′; reverse pri-
mer: 5′-ACAAGAAGCCGTCGATGATAACT-3′). The
relative occupancy of the immunoprecipitated factor at
SIRL-1 locus is estimated by using the comparative
threshold method 2ˆ(Ctmock–Ctspecific), where Ctmock and
Ctspecific are mean threshold cycles of PCR done in tripli-
cate on DNA samples from mock and specific immuno-
precipitation [24].
Bisulfite treatment and DNA methylation analysis
Primers for the bisulfite genomic sequencing (BGS) were
designed to cover a region 361 bp upstream and 335 bp
downstream to the transcription start site of VSTM1
(Additional file 3). DNA bisulfite treatment of the gen-
omic DNA isolated from freshly isolated monocytes and
neutrophils of respectively four donors of the CC and
TT genotype (functional cohort) was performed accord-
ing to the protocol described in EZ DNA Methylation-
Direct™ Kit (Zymo Research). For BGS, bisulfite-treated






with optimized conditions. The PCR products were
cloned into the TA cloning vector (Invitrogen, Life tech-
nologies). For both monocytes and neutrophils three
clones from each donor and sequenced using M13 for-
ward primer.
CpG islands (CGI) prediction
A Hidden Markov Model (HMM) based CGI prediction
for the VSTM1 gene locus was obtained from UCSC gen-
ome browser as custom tracks (http://genome.ucsc.edu/
cgi-bin/hgTracks) [25]. CpG islands (CGI) from DNA se-
quences and custom tracks were uploaded from Rafael
Irizarry lab (http://rafalab.jhsph.edu/CGI/).
Results
VSTM1 promoter-associated SNP rs612529 is an eQTL for
SIRL-1
We used whole blood eQTL data of 202 ethnic Chinese
donors (unpublished dataset) collected in Singapore to
determine if our previously reported inter-individual var-
iations in SIRL-1 levels [12, 16] are linked to SNPs. The
results described in Fig. 1a reveal a strong eQTL peak at
the promoter of the VSTM1 gene that encodes for SIRL-
1 (all cohorts used in the study are described in
Additional file 1). The effect was caused by a single SNP
(rs612529T/C) located 45 bp upstream of the transcrip-
tional start site (TSS) in the promoter region of VSTM1
(P = 8.13 × 10–13). We also used our previous data [18]
based on gene array analysis of monocytes and B cells
isolated from a genotype matched Chinese cohort of 15
individuals. Primary isolated monocytes from the T allele




Fig. 1 (See legend on next page.)
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donors exhibited a higher level of SIRL-1 mRNA expres-
sion, while the level was considerably lower in the C allele
donors (Fig. 1b). The mRNA levels gradually increased
from the CC over CT to TT genotype, resulting in a more
than tenfold difference between the two homozygous
genotypes of CC versus TT (P = 4.30 × 10–3). We vali-
dated this finding in a much larger dataset of 283
Caucasian individuals based on published eQTLs [19]
(P = 2.40 × 10–12) (Fig. 1c). The low expression allele was
less frequent in the Caucasians with allele frequency of
the C allele in Caucasian at 15.8% compared with 36.7% in
Chinese and 25.6% Japanese (Fig. 1d). No significant
eQTL association was observed for VSTM1 mRNA in B
cells isolated from the same donors in both datasets
(Fig. 1b and c).
Cell-type–specific regulation of SIRL-1 protein expression
in monocytes
Our eQTL association for rs612529 seems to affect
VSTM1 expression monocytes and not B cells. SIRL-1 is
expressed on various immune cells of the myeloid
lineage. To determine the effect of rs612529 monocyte
SIRL-1 at the protein level, we used flow cytometry to
analyze three genotype donors (Fig. 2a). Scatter analysis
with anti-SIRL-1 staining revealed allele-dependent ef-
fects on the amount of SIRL-1 surface expression only
on monocytes. Notably, no influence of the SNP was ob-
served for the granulocyte subset (Fig. 2a). On these cells
a high expression of the receptor was detected inde-
pendent of the genotype of rs612529. We then validated
the finding in a cohort of 44 donors by using a staining
panel of seven antibodies (Fig. 2b). The gating strategy
(Additional file 4) allowed the simultaneous quantifica-
tion of the SIRL-1 expression on various cells of the
myeloid lineage (monocytes, neutrophils, eosinophils,
basophils, myeloid dendritic cells (mDC), and plasmacy-
toid DC (pDC) as well as on lymphocytes (B cells, nat-
ural killer (NK) cells/T cells) (Fig. 2c). The analysis
confirmed the strong genetic association with SIRL-1
surface expression on monocytes (P = 2.4 × 10–9) as well
as the high but genotype-independent expression on
neutrophils. A slight effect of the rs612529 polymorph-
ism was observed also on eosinophils and basophils
(P = 0.0358 and P = 0.0077, respectively), while on
mDC, pDC, B cells, and NK cells/T cells, the SIRL-1
expression fell below detection limit (Fig. 2c).
Impact of rs612529 on the inhibition of ROS
We have shown previously that SIRL-1 inhibits the FcR-
mediated respiratory burst [12, 16]. In order to deter-
mine the functional implications of the polymorphism,
we analyzed the antibody-induced ROS production in
monocytes based on the genotype of rs612529. Depend-
ing on differentiation and maturation, monocytes ex-
press varying amounts of FcR specific for IgG (FcγRIII,
CD16), IgE (FcεRI), and IgA (FcαR, CD89). Our flow cy-
tometry analysis on ex vivo monocytes revealed that the
SIRL-1 expression was highest on monocytes expressing
the Fc receptor for IgA (Fig. 3a, Additional file 5). More
than 90% of the FcαR+ cells co-expressed SIRL-1 (Fig. 3a,
right panel). Hence, for the follow-up ROS analysis, the
FcR-induced respiratory burst was induced using immo-
bilized IgA. The resulting data, as shown in Fig. 3b,
demonstrate that exposure of primary monocytes to IgA
resulted in a strong production of ROS. Simultaneous
ligation of SIRL-1 with an agonistic antibody resulted in
an rs612529 allele-dependent reduction of the levels of
detectable ROS. This was confirmed with monocytes
isolated from a cohort of 30 genotyped individuals
(Fig. 3c). A gradual decrease in the inhibition from TT
over TC to CC was observed, a trend that matched the
decreasing amount of SIRL-1 on the surface of these
cells. This was particularly evident in a direct correlation
between the amount of SIRL-1 on the surface of the
cells and the inhibition of the IgA-induced ROS produc-
tion (Fig. 3d).
rs612529 regulates the recruitment of PU.1 and YY1 to
the VSTM1 promoter
In order to determine if rs612529 modulates the binding
of essential transcription factor(s) we carried out
EMSAs. EMSA experiments performed with monocyte-
derived nuclear samples revealed allele-specific binding
of at least two different factors (Fig. 4a). Both factors
bound selectively to the T allele (“T probe”) but not the
C allele (“C probe”) of an oligonucleotide probe repre-
senting the 21 bp promoter segments of the SNP. Allele
specificity of the binding was confirmed by cold
(See figure on previous page.)
Fig. 1 rs612529 is an eQTL affecting SIRL-1 expression. a Manhattan plot of whole blood eQTLs located in the SIRL-1-encoding VSTM1 gene
region. The upper panel depicts the position of VSTM1 transcripts in relation to a CGI and the SNPs rs612529 and rs662850. The lower panel shows
the eQTL-association determined from whole blood samples of 202 Chinese individuals. The P value (expressed as –log10) is displayed on the
y-axis, the x-axis shows the location of the SNPs (rs612529 is indicated). b, c Genotype effect of rs612529 on the SIRL-1 mRNA expression monocytes
and B cells. The data were generated from cohort samples of 15 Chinese [18] and 281 Caucasian individuals [19]. The number of individuals per
genotype is indicated on the x-axis; the y-axis represents the SIRL-1 mRNA expression levels depicted as log2 value. d Allele frequencies of rs612529 in
three major ethnical groups. The pie charts display the frequencies of the C allele (red) and the T allele (blue) for Caucasian, Han Chinese, and Japanese
based on HapMap
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(See figure on previous page.)
Fig. 2 Cell-type–specific effect of rs612529 on SIRL-1 surface expression. a Flow cytometry analysis of whole blood samples. Whole blood samples
were stained with a SIRL-1 specific antibody (right panel) and an isotype-matched control antibody (left panel). The staining is shown vs. the side
scatter (SSC-A), which allows a simple discrimination of granulocytes, monocytes, and lymphocytes. The plots are representative examples of
individuals with the rs612529 genotype TT, TC, and CC. Arrows indicate the gradual increase in SIRL-1 staining on monocytes. b Genotype-
dependent SIRL-1 expression on various cell types. SIRL-1 staining (red) in reference to the isotype control (black) is shown for each of the three
rs612529-genotypes for myeloid cells (monocyte, neutrophil, eosinophil, basophil, mDC, and pDC) and two lymphocyte subsets (B cell, NK cell/T
cell). Data were generated by flow cytometry from whole blood samples after gating on the respective cell subset (gating strategy is displayed in
Additional file 4). c Cohort-wide distribution of the SIRL-1 expression. The dot plots summarize the SIRL-1 FACS data for a cohort of 44 genotype-
matched individuals
Fig. 3 Allele-specific inhibition of IgA-induced ROS production by SIRL-1. a Comparison of the SIRL-1 expression on monocytes expressing FcγRIII-,
FcεRIa- or FcαR-receptors. Flow cytometry analysis of the SIRL-1 surface expression is shown for monocytes gated on the expressing of the Fc-receptors
FcγRIII, FcεRI or FcαR (gating strategy is shown in Additional file 5). The SIRL-1 specific staining (black lines) is shown in reference to the isotype control
(gray). b Allele-dependent inhibition of ROS production. FcαR-mediated ROS production is shown for primary monocytes induced by plate-bound IgA
in the presence of agonistic anti-SIRL-1 antibodies (filled circle) or isotype-matched control antibody (open circle). Representative examples are shown
for each of the three rs612529-genotypes. ROS production was measured by ELISA at λEx/λEm = 545/590 nm using H2O2 sensitive Amplex Red; the units
represent background corrected relative fluorescence unit (RFU). c ROS inhibition obtained for a cohort of 30 genotyped donors. The plots display the
SIRL-1 surface expression (left panel) and the percent inhibition of the IgA-induced ROS production (right panel) in reference to the respective rs612529
genotype. d The correlation of SIRL-1 expression with the inhibition of IgA-induced ROS production. The correlation shown is 30 individuals. Dashed
line represents the linear regression. rs612529 genotype is indicated by the color code (TT: blue, CT: gray; CC: red)
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competition experiments, since unlabeled T probe could
out-compete both factors, while the unlabeled C probe
had no effect on their binding to the 32P-labeled T
probe.
In silico analysis by JASPAR (http://jaspar.binf.ku.dk/)
and TRANSFAC (http://www.gene-regulation.com/)
predicted binding by PU.1, MZF-1, and YY1 (Additional
file 6). EMSA competition of the radiolabeled T
probe with unlabeled oligonucleotides representing the
consensus binding sequences of these transcription factors
suggested band 1 to be formed by PU.1, while band 2 de-
rived from YY1 (Fig. 4b; Additional files 2 and 7). The
identity of the two factors was formally confirmed by
super-shift assays, in which the PU.1-specific and YY1-
specific antibodies super-shifted and/or blocked the com-
plex formation with the T probe (Fig. 4c).
The allele-specific interaction of PU.1 with the VSTM1
promoter region in monocyte-derived nuclear samples
Fig. 4 rs612529 C/T controls the binding of PU.1/YY1 to the VSTM-1 promoter. a Allele-specific binding to rs612529. EMSA experiments with
nuclear extracts from monocytes were carried out with radiolabeled probes representing the C allele (“C probe;” lanes 1–7) or the T allele of
rs612529 (“T probe;” lanes 8–14). In a “cold” competition, the binding to the radiolabeled probes was competed with unlabeled C probes (lanes
2–4 and 9–11) or T probes (lanes 5–7 and 12–14). Bands 1 and 2 are two bands formed by allele-specific binding; “N.S.” indicates a non-specific
band. b Competition with consensus binding motifs of predicted candidate factors. Binding to the T probe was competed with unlabeled probes
representing consensus binding motifs for MZF-1, PU.1 and YY1 (PBX was used as control). Binding of each factor was competed with the optimal
consensus sequence as well as a mutated variant to which the binding was abolished (sequences are listed in Additional file 7). c Super-shift
assays. Super-shift assays were carried out with the T probe and antibodies against MZF-1 (lane 2), PU.1 (lane 3), Ets1 (lane 4), Sp1-B (lane 5), GATA1
(lane 7) CREB1 (lane 8), and YY1 (lane 9) or isotype-matched control antibodies (lanes 1 and 6). Super-shifted bands and bands lost by the antibody
treatment are indicated by red arrows. d PU.1-ChIP assay. A ChIP assay with nuclear samples from monocytes of four CC and five TT donors (rs612529)
was carried out with PU.1-specific antibodies (red dots) or isotype-matched control antibodies (blue dots). PU.1 occupancy, depicted as fold change
compared to the isotype, was determined by quantitative PCR amplification of the respective region in the VSTM-1 promoter (Additional file 3)
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was also confirmed in ChIP assays (Fig. 4d). DNA frag-
ments precipitated from four CC and five TT donors
with PU.1-specific antibodies were analyzed by quantita-
tive PCR with a primer pair covering a region of the
VSTM1 promoter including the rs612529 SNP
(Additional file 3). In line with the results from the
EMSA experiments, a significant increase in the amount
of VSTM1 DNA was detected in the PU.1 precipitate
from TT donors compared to CC donors (Fig. 4d). Thus,
in monocytes PU.1 is strongly associated with the ana-
lyzed VSTM1 promoter segment when rs612529 consists
of the T allele.
The allelic state of rs612529 is correlated with the
methylation of VSTM1 in monocytes
Epigenetic mechanisms facilitate the response to the
changes in the environment through modulating the
gene expression. For example, the methylation of CpG
pairs triggers condensation of the DNA, which affects
the interaction with transcription factors and other regu-
latory factors controlling gene expression [26]. This
mechanism seems to be relevant also for VSTM1 as in
lymphoma cells (which do not exhibit any SIRL-1 ex-
pression) the silencing of the gene is associated with the
methylation of some CpG pairs located within the first
exon [27]. An in silico scan (http://rafalab.jhsph.edu/
CGI/) [25] suggested the presence of a CGI at the start
of VSTM1. It completely covered exon 1, extending from
the promoter region towards intron 1 (Fig. 5a). A seg-
ment of that region of about 700 bp (411 bp upstream
and 282 bp downstream of the TSS contained a total of
30 CpG pairs including one CpG-SNP formed by the C
allele of rs612529 (Additional file 3).
In order to study a potential role of the rs612529
CpG-SNP in the control of the monocyte-specific SIRL-
1 expression, we analyzed cytosine methylation by bisul-
fite sequencing. A total of eight donors (four CC geno-
type and four TT genotype) were used to determine the
influence of the allelic state in both eQTL relevant
monocytes and allele-independent neutrophils (Fig. 5b
and c). While the CpG-SNP itself would appear to be a
potential site for an allele-specific methylation, it was ap-
parently not a target for modification, as it was found to
be located in a 54-bp core region containing six add-
itional CpG pairs, which were constitutively demethy-
lated in all samples analyzed. While the CpG-SNP was
not directly affected by epigenetic modifications, it had a
strong and cell-type–specific effect on the general
methylation state in the analyzed gene region. In line
with the bright but allele-independent surface expression
detected by FACS (compare Fig. 2) neutrophils exhibit
demethylated CpG elements both in the CC and the TT
donors (Fig. 5b). In monocytes, however, only TT do-
nors had a demethylated VSTM1 promoter, while the
gene segment was almost completely methylated in CC
donors (Fig. 5c). Thus, in monocytes the formation of a
CpG pair by the C allele of rs612529 seems to promote
the methylation of other CpG pairs in the region results
in a silencing of the locus (compare Fig. 2).
Genetic association of rs612529 to AD phenotype
From earlier reports, it was hypothesized that allergic
and inflammatory skin diseases are linked to oxidative
stress [28, 29]. Since SIRL-1 acts as a balancing factor
for the antibody-induced ROS production by monocytes,
we evaluated whether the allelic state of rs612529 had
any influence on the manifestation of inflammatory skin
diseases. We used an existing allergy cohort for
rs612529 genotype association studies [20, 30]
(Additional file 1). Association analysis for rs612529 in
324 clinically diagnosed AD cases and 486 healthy con-
trols identified a significant association of P < 0.05 with
the C allele present at a higher frequency in patients
than in healthy controls (OR = 1.3; P = 4.00 × 10–6). The
same trend was also observed in two larger cohorts, one
Chinese [21] and one Caucasian [22] (Table 1). Upon
combining all three independent cohorts, the association
of rs612529 to AD risk remained significant with a Meta
P value of 1.14 × 10–6 in a combined sample size of
2536 AD cases against 4118 controls. Thus, the low sur-
face expression of SIRL-1 in monocytes associated with
the C allele potentially increases risk for inflammatory
skin diseases such as dermatitis.
Discussion
In this study, we significantly associate the previously re-
ported cell-type–specific variations in SIRL-1 expression
to a genetic cause. A single SNP located in the promoter
region mediates the epigenetic silencing of the entire
gene locus, a process presumably mediated by the allele-
specific recruitment of PU.1/YY1. The allelic effect is
particularly evident in monocytes, where the C allele of
rs612529 is associated with a near complete lack of
SIRL-1 expression. This in turn results in a diminished
control of pro-inflammatory reactions, evidenced by the
failure of SIRL-1 agonists to dampen the production of
Fc-receptor induced ROS in these cells. Genetic associ-
ation results in independent cohorts suggest that this is
associated consistently with an increased risk of AD.
We then demonstrated allele-specific binding of PU.1
to the promoter region of VSTM1 using follow-up func-
tional experiments such EMSA and ChIP assays. This
transcription factor PU.1 has been shown to be a master
regulator of myeloid cell development, which could ex-
plain the observed specificity of the SIRL-1 expression in
cells of this lineage [31–33]. PU.1 forms complexes with
various regulatory factors chromatin remodelers, includ-
ing DNA methyltransferases and demethylases to
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activate or repress transcription [34]. A recent study has
shown that in non-differentiated monocytes, PU.1 can
act as docking site for the demethylase, Tet2 [35]. In
these cells the recruitment of Tet2 by PU.1 leads to the
targeted demethylation of the respective gene locus. In
line with this observation we therefore hypothesize that
the allele-dependent methylation of the VSTM1 gene re-
ported here can be explained by the conditional recruit-
ment of Tet2 or other demethylases as a result of the
allele-specific binding of PU.1 to rs612529 (Additional
file 8). In monocytes rs612529 would thus represent a
genetic master switch for the epigenetic control of SIRL-
1 expression by CpG demethylation.
Mechanistically, the methylation of CpG promotes the
compaction of chromatin by providing interaction sites
for methyl-CpG-binding proteins (MBPs) [24, 36, 37].
Hence, CpG-SNPs, which allow methylation in an allele-
dependent way, are often associated with function
[38–40]. In this context, it is interesting to note that
rs612529 is a CpG-SNP where the C allele forming
the CpG pair is associated with the epigenetic silencing of
the VSTM1 gene. However, in contrast to conventional
CpG-SNPs, it is not a direct target for methylation. In-
stead of acting as a simple “switch” to close the chromatin,
it rather functions as a genetic/epigenetic regulator that
modulates the DNA methylation state by the recruitment
of CpG modifying enzymes. In this way, the effect of the
CpG-SNP becomes potentiated, as the methylation affects
not just a single CpG but also many other CpG sites in its
vicinity. Subtle changes associated with the allelic switch-
ing between C and T therefore translate into extensive
epigenetic alterations of the gene, which makes rs612529
a master genetic regulator of the VSTM1 gene in
monocytes.
We then evaluated if the causal SNP we identified,
rs612529, has potential pathological implications, given
the striking variations in SIRL-1 surface expression ob-
served on monocytes. By using the allelic states of the
SNP as proxy for the expression levels in these cells we
could establish AD as being associated with a low SIRL-
1 expression in these cells. AD is a chronic inflammatory
skin disease affecting 60 million people in Europe and
the USA [41]. The pathophysiology of AD is a result
from a complex interplay of host genetic factors, envir-
onmental triggers, skin integrity, immune balance, and
the skin microbiome [42]. Thus, a tight control of the
immune response is needed to ensure effective pathogen
defense without collateral damage to the protective skin
layers. IgE is one of the determinants predisposing factor
for AD. However, earlier reports have shown that in
early childhood, elevated levels of IgE do not seem to
correlate with disease manifestations or severity of AD
[43]. Moreover, some evidence pointing towards a pos-
sible role of IgA derives from an earlier report indicating
that patients with selective IgA deficiency have an in-
creased incidence of atopic dermatitis [44].
(See figure on previous page.)
Fig. 5 Allele and cell type-dependent methylation of the VSTM1 gene promoter. a Schematic overview of the analyzed 693 bp region of the
VSTM1 gene locus (–1 to –388 upstream and +1 to +305 downstream to TSS). The location of a predicted CGI is indicated together with the
position of individual CpG pairs (solid black lines); the CpG-SNP formed by rs612526 is indicated by a red box. The location of the first exon in the
transcript variants of VSTM1 (covered in the C-methylation assay) is represented by solid blue vertical lines (the sequence of the 693 bp region is
shown in Additional file 3). b Allele-independent C-methylation in neutrophils. The methylation of CpG pairs in the 693 bp region was analyzed
by bisulfite sequencing. The methylation state of each CpG element is represented by circles (full circle: methylated, empty circle: demethylated);
the location of the TSS as well as of rs612529 is indicated. The methylation state in the cells is shown as a set of three independently sequenced
clones each obtained from four different donors of the rs612529 CC genotype (donors 1–4) and the TT genotype (donors 5–8). Red circles indicate
CpG pairs of the constitutively demethylated core region. c Allele-dependent methylation in monocytes. The CpG-methylation state is shown for
monocytes, which were isolated from the same donors described above for the neutrophils
Table 1 Association of rs612529 with AD
Referencesa Populationb Casesc (n) Controlsd (n) Effect allelee Effect allele frequencyf OR (95% CI)g P valueh
[15] Caucasian 1200 2270 C 0.209 1.12 (1.15–1.29) 1.26 × 10–3
[14] Chinese 1012 1362 C 0.322 1.15 (1.07–1.30) 2.6 × 10–2
[12, 13] Chinese 324 486 C 0.36 1.29 (1.10–1.45) 4 × 10–6
Combined 2536 4118 1.14 × 10–6
aInitial study describing the cohorts used for association
bEthnicity of the population under study
cNumber of atopic dermatitis cases
dNumber of controls
eAllele used for the calculating the odds ratio statistics
fAllele frequency of the effect allele in the individual study population
gOdds ratio estimated with 95% confidence interval
hP value estimated for the case control association study for atopic dermatitis phenotype in the individual study population
Meta P value is the P value calculated for all three cohorts combined using the Stoufier’s z trend meta-analysis which considers individual study P value sample
sizes and effect directions using Meta P program [20]
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SIRL-1 is an effective inhibitor of monocyte-derived
pro-inflammatory reactions such as FcR-induced ROS
production. In our study, we show that blood monocytes
represent a heterogeneous population characterized by
different Fc receptors. In Fig. 3a and Additional file 5,
FcαR+ monocytes co-segregate with a high expression of
SIRl-1 expression. This is not observed in FcγRIII+ and
FcεR+ monocytes, the latter being expressed on a very
small subset of monocytes. As such, we examined if co-
activating of FcαR and SIRL-1 with human IgA and anti-
SIRL-1 mAb would influence the capacity of monocytes
to generate ROS. We show the capacity of SIRL-1 to
modulate ROS production in monocytes is a function of
VSTM1 genotype. The association of the low expressing
C allele with AD thus leads us to hypothesize that inhibi-
tory regulation by SIRL-1 of monocytes or monocyte-
derived cells plays a key role in skin homeostasis.
Conclusion
In summary, our study introduces with rs612529 an im-
portant genetic factor influencing the risk for skin in-
flammation. The identification of this link was made
possible by defining an eQTL associated with these fluc-
tuations from the whole blood data of our Chinese co-
hort and using the genotypes to mine pre-existing
genetic association databases. A growing number of
eQTL and GWAS data have been published already but
only a fraction of the GWAS datasets are publicly ac-
cessible so far. Given the power the approach has to un-
cover new and unexpected links between genetically
controlled phenotypes and disease manifestation, it ap-
pears to be mandatory that more of the “large data,” in-
cluding eQTL and GWAS, has to be compiled and
curated in easily accessible repositories which are open
for the general scientific community. In the case of
SIRL-1 it not only helped to understand the role of the
receptor in controlling immune cells, it also identified a
novel candidate target for the treatment of AD. The
identification of the as-yet unknown ligand(s) of SIRL-1
may thus open up new avenues to control or suppress
the manifestation of the inflammatory skin disease.
Additional files
Additional file 1: Cohorts used in the study. The data for this study
were collected from seven different cohorts. Four of these cohorts were
established for the functional association studies (eQTL, FACS analysis,
ROS assay, DNA methylation, and ChiP assay), while the three other
cohorts were used for the genetic association studies with atopic
dermatitis (AD). Size of the cohorts as well as ethnicity and appropriate
reference are provided for each cohort. (PPTX 80 kb)
Additional file 2: Oligonucleotide sequences of probes used in EMSA
experiments. The table lists the sequence of oligonucleotides used as
radiolabeled probes or as cold competitors in EMSA. VSTM1 C and T
probe sequences represent the two allelic variants of a 25-bp region in
the VSTM1 promoter containing the rs612529 SNP. Consensus and
mutant oligonucleotides are based on consensus binding sites of the
respective transcription factor. (PDF 51 kb)
Additional file 3: VSTM1 promoter sequence. The sequence of the
region 411 bases upstream of the TSS and 282 bases downstream
(untranslated region, Exon1, and part of Intron 1 of VSTM1 transcript) was
obtained from UCSC genome browser (https://genome.ucsc.edu/). The
location of rs612529 T/C (underlined) as well as of each CpG site is
indicted (red bold font). The transcription start site is indicated by “TSS,”
the translational start by the start codon ATG. The transcribed region is
indicated by small letters. Primers for bisulfite sequencing (F1/F2 and B1/
B2) as well as the primer pair used for rs612529 genotyping and ChiP
analysis are indicated by empty arrows. (PDF 161 kb)
Additional file 4: Gating strategy for the flow cytometry analysis of
SIRL-1 expression on whole blood samples. Whole blood samples stained
with antibodies specific for CCR3, CD16, CD123, CD14, FcεRIα, and HLA-
DR were counterstained with either anti-SIRL-1 or isotype-matched
control antibody. Gates allowing the simultaneous analysis of the SIRL-1
staining on neutrophils, eosinophils, basophils, monocytes, mDC, pDC, B
cells, and NK & T cells are indicated. (PDF 210 kb)
Additional file 5: Gating strategy for monocytes expressing FcγRIII,
FcεRIα, or FcαR. PBMCs were stained with antibodies specific for FcγRIII
(CD16), FceRIα, FcαR (CD89), and CD14 together with anti-SIRL-1, or
isotype-matched control antibody. Monocytes were gated based on
scatter properties (SSC-A and FSC-A) and live/dead-staining (AmCyan).
Gates for FcγRIII+ monocytes, FcεRIα +monocytes, and FcαR+ monocytes
are indicated in plots displaying the CD14 staining vs. the respective
Fc-receptor. (PDF 297 kb)
Additional file 6: In silico prediction of transcription factors with allele-
specific binding to rs612529. The web based prediction tools JASPAR
(A) and TRANSFAC (B) were used to identify potential transcription factor
binding sites in the VSTM1 promoter region affected by the allelic
variations of rs612529 T/C. Only sites predicted with a binding score
greater than 5.0 (JASPAR) and 0.9 (TRANSFAC) were selected for further
analysis. The nucleotide underlined in red indicates the location of
rs612529 within binding motif of the respective TF. Yellow shaded rows indicate
transcription factors predicted to be highly specific for T allele.5. (PDF 55 kb)
Additional file 7: EMSA competition of PU.1 (ETS family) and YY1
consensus probes with rs612529 probes. EMSA experiments were
performed with radiolabeled probes representing the consensus binding
sequence of PU.1 and YY1. A EMSA competition experiment with
consensus PU.1-probe. Nuclear extracts from primary monocytes were
exposed to radiolabeled PU.1 consensus alone (lane 1) or together with
excess of unlabeled PU.1 consensus probes (lane 2), PU.1 mutant probes
(lane 3), or increasing amounts of rs612529 C (lanes 4–6) or T probes
(lanes 7–9). The competitors were added to the binding reactions at
increasing concentrations prior to the incubation with probe. B EMSA
competition experiment with consensus YY1-probe. Radiolabeled YY1
probe was used alone (lane 1) or with excess of unlabeled YY1 probe
(lane 2), YY1 mutant probe (lane 3), or increasing amounts of rs612529 C
(lanes 4–7) or T probes (lanes 8–11). (PDF 243 kb)
Additional file 8: Model on the potentiating effect of a regulatory CpG-
SNP. A Conventional vs. regulatory CpG-SNPs. The methylation of CpG
pairs results in the condensation of chromatin due to a tighter packaging
of the histone-DNA complexes (open circle: non-methylated CpG, closed
circle: methylated CpG). While a conventional CpG-SNP can assist this
process by providing only one additional allele-dependent methylation
site (middle panel), a regulatory CpG-SNP (such as rs612529) modulates
the recruiting of CpG-modifying enzymes (right panel). In the case of
rs612529, this seems to be mediated by the allele-specific binding of
PU.1 to the T allele of the CpG-SNP. In monocytes PU.1 was reported to
bind the demethylase Tet-2. B Potentiating effect. Recruitment of Tet-2
mediates the chromatin-opening by facilitating the demethylation of all
CpG pairs in the vicinity. The epigenetic effect is allele-specific (T allele)
and direction of the direction probably cell-type–dependent. (PDF 415 kb)
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